Gracecast Lung Cancer Audio
The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:33:48
- Mas informaciones
Informações:
Sinopsis
Dr. Jared Weiss, medical oncologist from the Univ. of Pennsylvania, covers limited data and current clinical trials addressing potential role of EGFR inhibitors, and particularly Tarceva (erlotinib), as post-surgical treatment for advanced NSCLC.
